LifeCell Adds NovaSeq 6000 DNA Sequencer to Its Diagnostic Technology Platform, Health News, ET HealthWorld

[ad_1]

Chennai: In order to perform genome sequencing more efficiently and cost effectively, diagnostic solutions provider LifeCell announced the addition of the “NovaSeq 6000” sequencing system to its diagnostic technology platform.

NovaSeq 6000 is a high throughput sequencing system that can generate high throughput and high quality sequencing data in a short timeframe, provide rapid diagnosis of sick neonates admitted to intensive care units, provide rapid and reliable diagnostic services to pregnant women who have a history of genetic abnormalities, are able to sequence viral and bacterial genomes for efficient patient management, and conduct large-scale genomics projects with large volumes at a unprecedented depth and genome coverage.

LifeCell suggested that the advanced technical support provided by Illumina’s NovaSeq 6000 system can help improve scalability, support a diverse range of applications, and simplify workflow. The system will help to conduct studies and test large amounts of data in a faster and more affordable manner.

Speaking on adding a sequencing system to improve their diagnostic solutions, Ishaan Khanna, CEO and Executive Director of LifeCell International Private Ltd. said, “The advanced sequencing system will allow us to offer the most comprehensive suite of genetic testing services that find important applications in whole genome sequencing, transcriptome, metabolomics as well as viral, bacterial and agro studies. -genomics. Using this high throughput genomics solution, we will be able to lead big data projects that are not only of clinical importance, but can also have an impact at the national level.

Speaking of the applications of high throughput sequencing systems, Dr Divya Agarwal, Medical Geneticist, Apollo Hospital and Advisor, LifeCell Diagnostics said, “The application of high throughput sequencing is critical to the generation of high quality data and to fast turnaround time. accelerate the development of new sequencing panels in multispecialty segments, including oncology. NovaSeq’s knowledge will produce transformative results, ensuring rapid diagnosis and effective patient risk reduction approaches. ”

[ad_2]
Source link

Comments are closed.